WHO WE ARE
Our Mission: Enabling Better Healthcare
Our mission is to offer patients the best possible medical treatment through intelligent software solutions.
Our mission is to offer patients the best possible medical treatment through intelligent software solutions.
Climedo is the leading all-in-one eCOA and EDC platform for real-world and late-phase clinical studies. Powered by Autonomous Data Capture (ADC), study data flows in from the source with near-zero manual entry, delivering real-time insights on efficacy and safety directly to HCPs and KOLs. Founded in Munich in 2017, trusted by pharma, medtech, CROs and academia, over 2 million patients enrolled across 200+ studies to date.
This boosts awareness, stimulates scientific dialogue and accelerates the launch success of new medical innovations, thus reaching more patients faster.
Climedo was founded in Munich in 2017 and developed together with clinicians who work in clinical research every day. With them, we saw the pain of manual data entry, site recruitment challenges and regulatory pressure. We saw how legacy EDC systems slowed studies down and created friction at every step. That is why we built a platform that removes this friction, starting with Autonomous Data Capture.
Climedo removes manual data entry wherever study data can flow from the source into the eCRF, with a person approving every value. Autonomous Data Capture is not a feature. It is the creation of a new category.
Study data flows from the source into the eCRF, with a person approving every value.
Scientific dialogue during ongoing studies.
Study setup in 3 to 5 days instead of 2 to 3 weeks.
Guided by our From Data to Dialogue whitepaper.
Climedo's culture is built on ambition, empathy and confidence. We celebrate success but stay grounded, and we are constantly evolving. Our innovation engine lets us ship AI features fast, and we build them together with the people who use them.
Co-Founder and CEO
Co-Founder and CTO
Co-Founder
